Uncover key drivers, emerging technologies, and competitive movements shaping the hospital and nursing home probiotics market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Hospital And Nursing Home Probiotics Market?
The hospital and nursing home probiotics market size has experienced rapid growth in recent years. It is anticipated to expand from $1.69 billion in 2025 to $1.88 billion in 2026, progressing at a compound annual growth rate (CAGR) of 11.4%. The observed growth historically can be ascribed to an increasing understanding of gut health advantages, elevated antibiotic consumption leading to digestive problems, the expanding elderly demographic within nursing facilities, the proliferation of clinical nutrition methods, and the expanding accessibility of probiotic formulations.
The hospital and nursing home probiotics market is anticipated to experience robust expansion over the next few years, with its size expected to reach $2.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This projected growth during the forecast period is attributable to an escalating focus on microbiome-based health management, a growing demand for immune support solutions, the increasing occurrence of gastrointestinal disorders, the broadening of hospital-based preventive care programs, and the rising application of probiotics in long-term care facilities. Prominent trends observed in this period include the increased utilization of probiotics within clinical nutrition protocols, their wider adoption for the care of the elderly and immunocompromised individuals, their growing integration into preventive healthcare regimens, the expansion of probiotic formulations tailored to specific conditions, and the increasing acceptance of probiotics as an adjunct therapy in hospitals.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20834&type=smp
What Drivers Are Supporting Technological Adoption In The Hospital And Nursing Home Probiotics Market?
The escalating occurrence of gastrointestinal disorders is anticipated to stimulate the expansion of the hospital and nursing home probiotics market moving forward. These conditions refer to a variety of ailments impacting the digestive tract, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The rising frequency of gastrointestinal disorders is linked to elements such as poor dietary habits, increased intake of processed foods, sedentary lifestyles, and heightened stress levels. Hospital and nursing home probiotics aid in managing gastrointestinal disorders by re-establishing the balance of beneficial gut bacteria, fostering digestive wellness, and relieving symptoms like diarrhea, constipation, and bloating. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, by 2023, the number of individuals with Inflammatory Bowel Disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the growing prevalence of gastrointestinal disorders is propelling the growth of the hospital and nursing home probiotics market.
Which Segments Are Contributing To The Growth Of The Hospital And Nursing Home Probiotics Market?
The hospital and nursing home probiotics market covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health
2) By Formulation Type: Capsules, Powder, Liquid
3) By Patient Group: Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals, Nursing Homes, Healthcare Facilities
5) By Application: Gut Health, Immunity
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD
2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD): Crohn’s Disease, Ulcerative Colitis
5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration
What Trends Are Driving The Growth Trajectory Of The Hospital And Nursing Home Probiotics Market?
Leading companies in the hospital and nursing home probiotics market are concentrating on developing innovative products, specifically probiotic solutions, aimed at enhancing patient gut health, improving recovery times, and reducing antibiotic-associated side effects. Probiotic solutions are defined as products containing live microorganisms that offer health benefits when consumed in adequate amounts, typically by improving the balance of beneficial bacteria within the digestive system. For instance, in October 2024, Probi AB, a Sweden-based biotechnology company specializing in probiotics, launched Metabolic Health by Probi for healthcare settings. Metabolic Health by Probi is a clinically backed probiotic solution designed to support metabolic well-being, cardiovascular health, weight management, and blood pressure regulation by combining two proprietary probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).
Who Are The Major Companies Operating In The Hospital And Nursing Home Probiotics Market?
Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, Abbott Laboratories, Danone S.A., Yakult Honsha Co. Ltd., BioGaia AB, Lactalis Group, General Mills Inc., Arla Foods Group, Glanbia PLC, SymbioPharm GmbH, Klaire Labs, Procter & Gamble Company, Vitakem Nutraceuticals, Synlogic Inc., Bayer AG, Sanofi, Meiji Holdings Co. Ltd., Morinaga Milk Industry Co. Ltd., Otsuka Holdings Co. Ltd., Reckitt Benckiser Group plc
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Hospital And Nursing Home Probiotics Market?
North America was the largest region in the hospital and nursing home probiotics market in 2025. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Hospital And Nursing Home Probiotics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20834&type=smp
Browse Through More Reports Similar to the Global Hospital And Nursing Home Probiotics Market 2026, By The Business Research Company
Probiotics Packaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/probiotics-packaging-global-market-report
Probiotics Dietary Supplements Market Report 2026
Probiotics Food And Cosmetics Market Report 2026
https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model